Biophysical Regulation of Breast Differentiation
乳房分化的生物物理调节
基本信息
- 批准号:8204473
- 负责人:
- 金额:$ 29.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdhesionsAffectAreaBiological AssayBreastBreast CarcinomaCarcinomaCell Culture TechniquesCell ProliferationCellsCollagenCollagen FiberDepositionEnvironmentEpithelial CellsEventExtracellular MatrixFutureGene ExpressionGenesHealthHumanIn VitroIncidenceIntegrinsInvadedKnockout MiceLinkMammary Gland ParenchymaMammary NeoplasmsMammary TumorigenesisMammary glandMammographic DensityMediatingMediator of activation proteinMicroinvasiveModelingMolecularMusNeoplasm MetastasisNoninfiltrating Intraductal CarcinomaOutcomePTK2 genePathologicPathway interactionsPatientsPhenotypePhosphorylationPlayRecurrent diseaseRegulationResistanceRiskRisk FactorsRoleSamplingSignal PathwaySignal TransductionSmall Interfering RNATestingTissue MicroarrayTissuesTransgenic MiceXenograft procedurebreast densitycell behaviorcollagenasedensitydesigndisorder riskextracellularhuman diseasein vivoinhibitor/antagonistknock-downmalignant breast neoplasmmouse modelphysical propertyprognostic indicatorpublic health relevanceresearch studyresponsesmall hairpin RNAtumortumor progression
项目摘要
DESCRIPTION (provided by applicant): An increase in the mammographic density of breast tissue is correlated to a four to six-fold increased risk of developing breast carcinoma, making it the single biggest risk factor for breast carcinoma. Despite this, the molecular mechanism by which breast density links to carcinoma formation is unknown. We have recently shown that in a mouse model of increased collagen deposition, mammary tumor incidence, invasion, and metastasis increase three-fold, suggesting that an increase in collagen per se is part of the mechanism by which increased breast density is correlated with increased risk in humans. The purpose of this proposal is to understand how physical properties of the ECM regulate breast cell behavior. Our hypothesis is that locally dense ECM enhances the formation of matrix adhesions that result in activation of signaling pathways linked to FAK, and that FAK is a central mediator by which matrix density regulates gene expression to promote proliferation and invasion. This hypothesis will be tested in the following Specific Aims: Aim 1: Define changes in the expression of proliferation and metastasis-associated genes regulated by collagen density and alignment. Gene expression of the proliferation and the metastasis gene signatures, will be determined in human breast carcinoma samples, using tissue arrays linked to patient outcome, and with DCIS and microinvasive DCIS. Metastasis genes will be screened by siRNA and shRNA knock-down for their role in mediating invasion into 3D matrices in vitro and in vivo. Aim 2: Test the hypothesis that FAK regulates proliferation and invasion in response to collagen density and alignment Tumors that are FAK-/- do not invade or metastasize in vivo, even in the context of a FAK+/+ stroma. We will use in vitro 3D invasion assays and our in vivo FAK-/- mice to investigate the role of FAK in cell proliferation, matrix alignment and 3D invasion. Conditional FAK knockout mice will be used to determine the role of FAK in enhanced tumor progression in the collagenase-resistant transgenic mouse model (Col1a1tm1Jae) having a dense collagen matrix. Phosphorylation of FAK at pY397 will be determined in mammary tissues from Col1a1 mice, mouse tumor, and human pathologic samples to determine if pY397FAK correlates to dense breast tissue in vivo. Aim 3: Test the link between collagen density, FAK and downstream signaling events, ERK, Src, and PI3K, in regulating cell proliferation and invasion. FAK-/- cells lose activation of ERK and PI3K pathways. Using pharmacologic inhibitors and siRNA/shRNA approaches, we will inhibit each of these pathways and determine their role in mediating the proliferation and invasion of human breast cells into dense and aligned collagen matrices in vitro. Xenografts of human carcinoma, and mice bearing tumors in wt and dense collagen stroma (Col1a1 mouse model) will be treated in vivo with pharmacologic inhibitors to test the role of these molecules in tumor progression in vivo.
PUBLIC HEALTH RELEVANCE: Understanding the role the physical properties of the extracellular matrix plays in cancer progression is of great health relevance as breast density accounts for a 4-6 fold increase in carcinoma risk. Moreover, we have found that collagen alignment carries a 5 fold risk of disease relapse, suggesting that understanding how collagen alignment occurs, and how it contributes to progression will help us understand breast carcinoma. These experiments are designed to understand the underlying molecular mechanisms by which the dense extracellular matrix regulates breast cell behavior and invasion and progression, and could suggest future targets for therapy.
描述(由申请人提供):乳腺组织乳房X线摄影密度的增加与发生乳腺癌的风险增加四至六倍相关,使其成为乳腺癌的单一最大风险因素。尽管如此,乳腺密度与癌形成之间的分子机制尚不清楚。我们最近发现,在胶原沉积增加的小鼠模型中,乳腺肿瘤的发病率、侵袭和转移增加了三倍,这表明胶原本身的增加是乳腺密度增加与人类风险增加相关的机制的一部分。该提案的目的是了解ECM的物理特性如何调节乳腺细胞的行为。我们的假设是,局部致密的ECM增强了基质粘附的形成,导致与FAK相关的信号通路的激活,并且FAK是基质密度调节基因表达以促进增殖和侵袭的中心介质。该假设将在以下特定目的中进行检验:目的1:定义由胶原密度和排列调节的增殖和转移相关基因表达的变化。将使用与患者结局相关的组织阵列以及DCIS和微创DCIS,在人乳腺癌样本中测定增殖和转移基因特征的基因表达。将通过siRNA和shRNA敲低筛选转移基因在体外和体内介导侵入3D基质中的作用。目标二:验证FAK调节增殖和侵袭以响应胶原密度和排列的假设FAK-/-肿瘤在体内不侵袭或转移,即使在FAK+/+基质的情况下。我们将使用体外3D侵袭试验和我们的体内FAK-/-小鼠来研究FAK在细胞增殖、基质排列和3D侵袭中的作用。条件性FAK敲除小鼠将用于确定FAK在具有致密胶原基质的胶原酶抗性转基因小鼠模型(Col 1a 1 tm 1 Jae)中增强肿瘤进展中的作用。将在Col 1a 1小鼠、小鼠肿瘤和人病理样品的乳腺组织中测定pY 397处FAK的磷酸化,以确定pY 397 FAK是否与体内致密乳腺组织相关。目的3:检测胶原密度、FAK和下游信号事件ERK、Src和PI 3 K在调节细胞增殖和侵袭中的联系。FAK-/-细胞失去ERK和PI 3 K通路的活化。使用药理学抑制剂和siRNA/shRNA方法,我们将抑制这些途径中的每一个,并确定它们在体外介导人乳腺细胞增殖和侵入致密和排列的胶原基质中的作用。将在体内用药理学抑制剂处理人癌的异种移植物和在野生型和致密胶原基质中携带肿瘤的小鼠(Col 1a 1小鼠模型),以测试这些分子在体内肿瘤进展中的作用。
公共卫生相关性:了解细胞外基质的物理性质在癌症进展中的作用具有很大的健康相关性,因为乳腺密度导致癌症风险增加4-6倍。此外,我们发现胶原蛋白排列具有5倍的疾病复发风险,这表明了解胶原蛋白排列如何发生,以及它如何促进进展将有助于我们了解乳腺癌。这些实验旨在了解致密细胞外基质调节乳腺细胞行为和侵袭和进展的潜在分子机制,并可能为未来的治疗提供靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patricia J Keely其他文献
R-Ras regulates β1-integrin trafficking via effects on membrane ruffling and endocytosis
- DOI:
10.1186/1471-2121-11-14 - 发表时间:
2010-02-18 - 期刊:
- 影响因子:2.700
- 作者:
Matthew W Conklin;Aude Ada-Nguema;Maddy Parsons;Kristin M Riching;Patricia J Keely - 通讯作者:
Patricia J Keely
Patricia J Keely的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patricia J Keely', 18)}}的其他基金
Matrix density promotes pro-tumorigenc hormone actions in breast cancer
基质密度促进乳腺癌中促肿瘤激素的作用
- 批准号:
8973155 - 财政年份:2014
- 资助金额:
$ 29.58万 - 项目类别:
Matrix density promotes pro-tumorigenc hormone actions in breast cancer
基质密度促进乳腺癌中促肿瘤激素的作用
- 批准号:
8696201 - 财政年份:2014
- 资助金额:
$ 29.58万 - 项目类别:
Use of antifibronectin agents to target fibrosis in mammary cancer
使用抗纤连蛋白药物治疗乳腺癌纤维化
- 批准号:
8585985 - 财政年份:2013
- 资助金额:
$ 29.58万 - 项目类别:
Use of antifibronectin agents to target fibrosis in mammary cancer
使用抗纤连蛋白药物治疗乳腺癌纤维化
- 批准号:
8692716 - 财政年份:2013
- 资助金额:
$ 29.58万 - 项目类别:
ECM Stiffness as a Regulator of Tumor Cell Dissemination and Dormancy
ECM 硬度作为肿瘤细胞传播和休眠的调节剂
- 批准号:
8555314 - 财政年份:2011
- 资助金额:
$ 29.58万 - 项目类别:
ECM Stiffness as a Regulator of Tumor Cell Dissemination and Dormancy
ECM 硬度作为肿瘤细胞传播和休眠的调节剂
- 批准号:
9130485 - 财政年份:2011
- 资助金额:
$ 29.58万 - 项目类别:
Mechanisms by which matrix stiffness regulates Rho
基质刚度调节 Rho 的机制
- 批准号:
8608250 - 财政年份:2009
- 资助金额:
$ 29.58万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 29.58万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 29.58万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 29.58万 - 项目类别: